Foresight regarding drug candidates acting on the succinate–GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Foresight regarding drug candidates acting on the succinate–GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment

Published:2021-12 Issue: Volume:144 Page:112298
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Liang Chengyuan,Li Juan,Tian Bin,Tian Lei,Liu Yuzhi,Li Jingyi,Xin Liang,Wang Jun,Fu Chao,Shi Zhenfeng,Xia Juan,Liang Yiting,Wang Kun

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference202 articles.

1. Insulin resistance, inflammation, and non-alcoholic fatty liver disease;Tilg;Trends Endocrinol. Metab. TEM,2008

2. Predicting and elucidating the etiology of fatty liver disease: a machine learning modeling and validation study in the IMI DIRECT cohorts;Atabaki-Pasdar;PLoS Med.,2020

3. Therapeutic effects of serum extracellular vesicles in liver fibrosis;Chen;J. Extracell. Vesicles,2018

4. Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα;Liang;Nat. Commun.,2019

5. Nonalcoholic fatty liver disease: from steatosis to cirrhosis;Farrell;Hepatology,2006

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Mechanism of Action of GPR91 Agonists and Antagonists: Insights from Molecular Dynamics Simulation;Chemical Research in Chinese Universities;2024-06-04

2. Succinate as a signaling molecule in the mediation of liver diseases;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-02

3. Potential impact of trained innate immunity on the pathophysiology of metabolic dysfunction-associated fatty liver disease;Clinical Immunology;2023-11

4. Ginsenoside Rk3 Regulates Nonalcoholic Steatohepatitis by Modulation of Intestinal Flora and the PI3K/AKT Signaling Pathway in C57BL/6 Mice;Journal of Agricultural and Food Chemistry;2023-06-08

5. Gut microbiome as a therapeutic target for liver diseases;Life Sciences;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3